Page last updated: 2024-08-24

nelfinavir and Pituitary Neoplasms

nelfinavir has been researched along with Pituitary Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Armour, M; Aziz, K; Gajula, RP; Hales, RK; Kleinberg, L; Lim, M; Phallen, J; Quinones-Hinojosa, A; Redmond, K; Salih, T; Salvatori, R; See, AP; Terezakis, S; Thiyagarajan, S; Tran, PT; Zeng, J	1

Other Studies

1 other study(ies) available for nelfinavir and Pituitary Neoplasms

Article	Year
Nelfinavir induces radiation sensitization in pituitary adenoma cells. Cancer biology & therapy, 2011, Oct-01, Volume: 12, Issue:7 Topics: Adenoma; Animals; Annexin A5; Apoptosis; Caspase 3; Cell Cycle; Cell Survival; Female; Humans; Mice; Mice, Nude; Nelfinavir; Neoplasms, Experimental; Phosphatidylinositol 3-Kinases; Pituitary Neoplasms; Prolactin; Proto-Oncogene Proteins c-akt; Radiation-Sensitizing Agents; Signal Transduction; TOR Serine-Threonine Kinases; Xenograft Model Antitumor Assays	2011

Article

Year

Nelfinavir induces radiation sensitization in pituitary adenoma cells.

Cancer biology & therapy, 2011, Oct-01, Volume: 12, Issue:7

Topics: Adenoma; Animals; Annexin A5; Apoptosis; Caspase 3; Cell Cycle; Cell Survival; Female; Humans; Mice; Mice, Nude; Nelfinavir; Neoplasms, Experimental; Phosphatidylinositol 3-Kinases; Pituitary Neoplasms; Prolactin; Proto-Oncogene Proteins c-akt; Radiation-Sensitizing Agents; Signal Transduction; TOR Serine-Threonine Kinases; Xenograft Model Antitumor Assays

2011